Human Nasopharyngeal Carcinoma Can Be Radiosensitized by Trichosanthin via Inhibition of the PI3K Pathway

Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm.2018.6719
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

FBXL10 Contributes to the Progression of Nasopharyngeal Carcinoma via Involving in PI3K/mTOR Pathway

Neoplasma
Cancer Research
2015English

ANXA6 Contributes to Radioresistance by Promoting Autophagy via Inhibiting the PI3K/AKT/mTOR Signaling Pathway in Nasopharyngeal Carcinoma

Frontiers in Cell and Developmental Biology
Developmental BiologyCell Biology
2020English

Capsaicin Induces Autophagy and Apoptosis in Human Nasopharyngeal Carcinoma Cells by Downregulating the PI3K/AKT/mTOR Pathway

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2017English

Honokiol-Mediated Inhibition of PI3K/mTOR Pathway

Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer ResearchAllergyImmunologyPharmacology
2009English

Apoptotic Effects of Xanthium Strumarium via PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2019English

Apatinib Inhibits Cell Proliferation and Induces Autophagy in Human Papillary Thyroid Carcinoma via the PI3K/Akt/mTOR Signaling Pathway

Frontiers in Oncology
Cancer ResearchOncology
2020English

Dual Inhibition of BRD4 and PI3K-AKT by SF2523 Suppresses Human Renal Cell Carcinoma Cell Growth

Oncotarget
Oncology
2017English

Embelin Prevents LMP1-induced TRAIL Resistance via Inhibition of XIAP in Nasopharyngeal Carcinoma Cells

Oncology Letters
Cancer ResearchOncology
2016English

PTPRG Suppresses Tumor Growth and Invasion via Inhibition of Akt Signaling in Nasopharyngeal Carcinoma

Oncotarget
Oncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy